| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a108c8153d3e907c41bc537b94bc333 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 |
| filingDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fe595365a812e19458ed012a299269d |
| publicationDate |
2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107663198-A |
| titleOfInvention |
Olmesartan medoxomil and its production and use |
| abstract |
Present invention relates particularly to the olmesartan medoxomil hydrate that olmesartan medoxomil hydrate, the present invention obtain, have the advantage that：Purity is high, and maximum contaminant is less than 1 ‰；Stability is good.The invention further relates to the application using this olmesartan medoxomil hydrate compositions treatment hypertension. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112321575-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112321575-B |
| priorityDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |